A Phase 1/2 Stud of the Safety and Efficacy of Ulocuplumab Combined with Nivolumab in Subjects with Advanced or Metastatic Solid Tumors
B
Bert O'Neil, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to test the effectiveness, safety, and tolerability of investigational drugs called ulocuplumab and nivolumab.
Description
The purpose of this study is to test the effectiveness, safety, and tolerability of investigational drugs called ulocuplumab and nivolumab.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Solid Tumor
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
19 Apr 2024.
Study ID: 1506034429
